Medicamen Biotech Limited
MEDICAMEQ

Medicamen Biotech Limited

Pharmaceuticals
Share price
₹286
Market cap
₹389 Cr
1Y return
▼ 29%

A research-led pharmaceutical company engaged in developing, manufacturing, and marketing generic finished dosage formulations alongside specialized oncology products. Established in 1993, the company operates across India's healthcare sector, delivering affordable medications to patients nationwide. Its distinctive positioning combines robust generic drug production capabilities with focused expertise in oncology therapeutics, serving both domestic markets and international customers through quality-driven operations.

Recent moves 1

Sanjay BansalDecreased
Sanjay Bansal sold 32,813 shares of Medicamen Biotech for ₹1.05 Cr at ₹321.29 apiece in the open market, reducing his stake from 0.76% to 0.51%.
28 Sept 2026
Read more

Track the whales in Medicamen Biotech Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1